This inhibition disrupts the preservation of the epithelial phenotype, fosters the progression of EMT, and contributes to the malignant advancement of pancreatic cancer.[231, 246] Our recent research findings indicate a notable rise in the expression of BACH1 within human ovarian epithelial carcinoma. This evidence concerns the gene BACH1 and pancreatic neoplasm.